Finance

Lists
ANAB:NASDAQ
AnaptysBio Inc
US$ ४८.६८
+०.१०%
(+०.०५०) 1D
अक्टोबर २, १५:५१:२३ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ANAB...
Open
US$ ४८.९७
High
US$ ४९.८३
Low
US$ ४८.२८
Mkt. cap
१.४६ अरब
Avg. vol.
५.३८ लाख
Volume
३.१७ लाख
52-wk high
US$ ७२.३६
52-wk low
US$ १९.६५
EPS
-US$ ०.८८
Beta
०.४५
Shares outstanding
२.९९ करोड
No. of employees
१०४
Open
US$ ४८.९७
High
US$ ४९.८३
Low
US$ ४८.२८
Mkt. cap
१.४६ अरब
Avg. vol.
५.३८ लाख
Volume
३.१७ लाख
52-wk high
US$ ७२.३६
52-wk low
US$ १९.६५
EPS
-US$ ०.८८
Beta
०.४५
Shares outstanding
२.९९ करोड
No. of employees
१०४
News stories
From web sources and news partners
About AnaptysBio Inc
CEO-
Employees१०४
Founded२००५
Headquartersसान डिएगो, क्यालिफोर्निया, संयुक्त राज्य अमेरिका
Sector-
Websiteanaptysbio.com
Analyst ratings
Based on 7 analysts giving stock ratings to ANAB in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for ANAB in the last 3 months.
Highest
Current US$ ४८.६८
US$ ९५.०० (+९५.१५%)
Average
US$ ८०.०० (+६४.३४%)
Lowest
US$ ६०.०० (+२३.२५%)
Analyst
Recommendation
Action
Price target
Projected
Date
Anupam Rama
J.P. Morgan
Buy
Reiterated
US$ ६०.००
+२३.३%
09/30/2026
David Risinger
Leerink Partners
Buy
Maintained
US$ ८१.००
+६६.४%
09/23/2026
Etzer Darout
Barclays
Buy
Maintained
US$ ७५.००
+५४.१%
09/22/2026
Michael Yee
UBS
Buy
Reiterated
US$ ७६.००
+५६.१%
09/22/2026
Joseph Pantginis
H.C. Wainwright
Buy
Reiterated
US$ ९५.००
+९५.२%
09/22/2026
Joseph Thome
TD Cowen
Buy
Reiterated
-
-
08/25/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
US$ ९३.००
+९१%
07/21/2026
David Nierengarten
Wedbush
Buy
Reiterated
US$ ७५.००
+५४.१%
03/31/2026
Emily Bodnar
H.C. Wainwright
Buy
Maintained
US$ ६६.००
+३५.६%
03/30/2026
Joon Lee
Truist Financial
Hold
Maintained
US$ ५०.००
+२.७%
03/09/2026
Alex Thompson CFA
Stifel Nicolaus
Buy
Maintained
US$ ८५.००
+७४.६%
03/05/2026
Yatin Suneja
Guggenheim
Buy
Reiterated
US$ १४०.००
+१८७.६%
03/04/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२६ मार्च
२०२६ जुन
२०२६ जुन
२०२६ सेप्टेम्बर
Revenue
२.५६ करोड
२.७५ करोड
२.७५ करोड
-
Cost of goods sold
३.४० करोड
-२७.०४ लाख
-
-
Cost of revenue
३.४० करोड
-२७.०४ लाख
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२.६२ करोड
१.५५ करोड
-
-
Operating expense
२.६२ करोड
१.५५ करोड
-
-
Total operating expenses
६.०२ करोड
१.२८ करोड
-
-
Operating income
-३.४६ करोड
१.४७ करोड
-
-
Other non operating income
-१.०० हजार
-१.०० हजार
-
-
EBT including unusual items
-५.२८ करोड
-४१.७४ लाख
-
-
EBT excluding unusual items
-५.२८ करोड
-४१.७४ लाख
-
-
Income tax expense
४०.०० हजार
-१८.१५ करोड
-
-
Effective tax rate
-०.०८%
४,३४८.१३%
-
-
Other operating expenses
-
-
-
-
Net income
-५.२९ करोड
१८.३९ करोड
-
-
Net profit margin
-२०६.९३%
६६८.९५%
-
-
Earnings per share
-१.८४
-
४.९३
-
Interest and investment income
२६.५३ लाख
१४.८६ लाख
-
-
Interest expense
-२.०९ करोड
-२.०३ करोड
-
-
Net interest expenses
-१.८२ करोड
-१.८८ करोड
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-३.४५ करोड
१.४७ करोड
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू